Phase I study of oral CP-4126, a gemcitabine derivative, in patients with advanced solid tumors.

F.E. Stuurman; E.E. Voest; A. Awada; P.O. Witteveen; T. Bergeland; P.A. Hals; W. Rasch; J.H.M. Schellens; A. Hendlisz

doi:10.1007/s10637-013-9925-z.

Phase I study of oral CP-4126, a gemcitabine derivative, in patients with advanced solid tumors.

F.E. Stuurman, E.E. Voest, A. Awada, P.O. Witteveen, T. Bergeland, P.A. Hals, W. Rasch, J.H.M. Schellens, A. Hendlisz

Clinical Pharmacology

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	959-966
Number of pages	8
Journal	Investigational New Drugs
Volume	31
Issue number	4
DOIs	https://doi.org/10.1007/s10637-013-9925-z.
Publication status	Published - 2013

Access to Document

10.1007/s10637-013-9925-z.

Cite this

@article{fb3a24d4b8fc43dc9ba3ed938590937d,

title = "Phase I study of oral CP-4126, a gemcitabine derivative, in patients with advanced solid tumors.",

author = "F.E. Stuurman and E.E. Voest and A. Awada and P.O. Witteveen and T. Bergeland and P.A. Hals and W. Rasch and J.H.M. Schellens and A. Hendlisz",

year = "2013",

doi = "10.1007/s10637-013-9925-z.",

language = "English",

volume = "31",

pages = "959--966",

journal = "Investigational New Drugs",

issn = "0167-6997",

publisher = "Kluwer Academic Publishers",

number = "4",

}

TY - JOUR

T1 - Phase I study of oral CP-4126, a gemcitabine derivative, in patients with advanced solid tumors.

AU - Stuurman, F.E.

AU - Voest, E.E.

AU - Awada, A.

AU - Witteveen, P.O.

AU - Bergeland, T.

AU - Hals, P.A.

AU - Rasch, W.

AU - Schellens, J.H.M.

AU - Hendlisz, A.

PY - 2013

Y1 - 2013

U2 - 10.1007/s10637-013-9925-z.

DO - 10.1007/s10637-013-9925-z.

M3 - Article

SN - 0167-6997

VL - 31

SP - 959

EP - 966

JO - Investigational New Drugs

JF - Investigational New Drugs

IS - 4

ER -